Buy Stocks Easy | About Us

April 20, 2021

ACRS

Buy Aclaris Therapeutics, Inc. Stock (symbol: ACRS) Easy Online

Company Name: Aclaris Therapeutics, Inc.

Symbol: ACRS

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

ACRS Current Share Price

Today's ACRS ( Aclaris Therapeutics, Inc. ) opening price: $1.7700

Yesterday's ACRS ( Aclaris Therapeutics, Inc. ) closing price: $1.8100

Aclaris Therapeutics, Inc. Stock ( symbol: ACRS ) Price Chart since IPO (2015):

12 Months Aclaris Therapeutics, Inc. Stock ( symbol: ACRS ) Price Chart

Popular Questions about Aclaris Therapeutics, Inc. Public Stock ( ACRS )

A: Aclaris Therapeutics, Inc. stock symbol (also called stock or share ticker) is ACRS

A: Aclaris Therapeutics, Inc. IPO (Initial Public Offering) took place on 2015

A: Aclaris Therapeutics, Inc.'s stock (ACRS symbol) price at ther IPO (initial Public Offering) was $1.7700

Q: Is ACRS stock worth buying at the moment?

A: The ACRS stock performance since 2019 are rather disappointing. If you had bought 1 share of Aclaris Therapeutics, Inc. stock (symbol: ACRS) at the beginning of 2019, at the opening share price of $6.9700, you would be left with exactly $1.7700 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Aclaris Therapeutics, Inc. Stock Easy Online

Aclaris Therapeutics, Inc. Stock Ticker Price Chart since IPO:

Aclaris Therapeutics, Inc. Stock Price Yesterday

Aclaris Therapeutics, Inc. Stock Price – Last Week

Aclaris Therapeutics, Inc. Stock Price – Last Month

Aclaris Therapeutics, Inc. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

https://seekingalpha.com/article/4305232-aclaris-therapeutics-inc-acrs-ceo-neal-walker-q3-2019-results-earnings-call-transcript

Aclaris Therapeutics, Inc. (ACRS) CEO Neal Walker on Q3 2019 Results - Earnings Call Transcript

Aclaris Therapeutics, Inc. (ACRS) CEO Neal Walker on Q3 2019 Result...

http://www.zacks.com/stock/news/563815/aclaris-divests-rhofade-to-epi-health-for-%2455m-shares-up

Aclaris Divests Rhofade to EPI Health for $55M, Shares Up

Aclaris (ACRS) divests worldwide rights to its rosacea drug, Rhofad...

http://www.globenewswire.com/news-release/2019/10/10/1928310/0/en/Aclaris-Therapeutics-Announces-Divestiture-of-RHOFADE.html

Aclaris Therapeutics Announces Divestiture of RHOFADE®

WAYNE, Pa., Oct. 10, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutic...

http://www.globenewswire.com/news-release/2019/10/08/1927000/0/en/Aclaris-Therapeutics-Files-Patent-Infringement-Lawsuit-Against-Taro-Pharmaceuticals-Inc-for-Filing-an-ANDA-for-a-Generic-Version-of-RHOFADE-oxymetazoline-hydrochloride-cream-1.html

Aclaris Therapeutics Files Patent Infringement Lawsuit Against Taro Pharmaceuticals, Inc. for Filing an ANDA for a Generic Version of RHOFADE® (oxymetazoline hydrochloride) cream, 1%

WAYNE, Pa., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutic...

http://www.zacks.com/commentary/547134/top-ranked-momentum-stocks-to-buy-for-october-3rd

Top Ranked Momentum Stocks to Buy for October 3rd

Top Ranked Momentum Stocks to Buy for October 3rd

http://www.zacks.com/commentary/538794/top-ranked-momentum-stocks-to-buy-for-september-27th

Top Ranked Momentum Stocks to Buy for September 27th

Top Ranked Momentum Stocks to Buy for September 27th

http://www.zacks.com/stock/news/536698/aclaris-therapeutics-inc-acrs-shares-march-higher-can-it-continue

Aclaris Therapeutics, Inc. (ACRS) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor i...

https://seekingalpha.com/article/4293491-one-late-stage-study-way-aclaris-moves-one-inch-closer-commercialization

With One Late-Stage Study Out Of The Way, Aclaris Moves One Inch Closer To Commercialization

Aclaris Therapeutics announced that it had achieved positive result...

http://www.zacks.com/stock/news/535161/aclaris-acrs-moves-to-buy-rationale-behind-the-upgrade

Aclaris (ACRS) Moves to Buy: Rationale Behind the Upgrade

Aclaris (ACRS) might move higher on growing optimism about its earn...

All right reserved Buy Stocks Easy , 2019.